PROTECTIVE EFFECTS OF S-ADENOSYL-L-METHIONINE ON POST-HEPATECTOMY LIVER FUNCTION

苏昭然,荚卫东,许戈良,马金良,李建生,葛勇胜,余继海

DOI: https://doi.org/10.3969/j.issn.1006-4761.2011.01.009

2011-01-01

Abstract:Background To investigate the protective effects of S-adenosyl-L-methionine (SAMe) therapy on post-hepatectomy residual liver function. Patients and methods We studied 59 patients underwent resection of hepatocellular carcinoma. 29 paients were randomly assigned to receive postoperative intracenous SAMe treatment, and 30 were randomly assigned to a control group. The postoperative SAMe therapy consisted of SAMe 1000mg given intravenously for 5 days. The other postoperative treatment was standardized. Results At inclusion into the trial no significant differences were observed between the two groups with respect to sex, age, previous episodes of major complications of cirrhosis, Child classification and postoperative liver function tests, introperative blood lose, total time of hilar blocking and the extent of liver resection. The overall post-operative liver insufficiency at the end of the trial decreased from 26.7% in the control group to 6.9% in the SAMe group, and the difference was statistically significant (P=0.040). When patients with clamp time of hilar blocking less than 15 min were excluded from the analysis, the Serum total bilirubin on 5 and 7 preoperatively and he maximum value of postoperative Serum total bilirubin were significantly greater in the control group than in the SAMe group (P=0.049; P=0.030; P=0.040). Conclusions The present results indicate that the post-operative SAMe therapy may protect residual liver function in patients underwent hepatectomy, especially in those with long clamp time.